South Korea's Advancements in Medical Data and VR Therapy for Visual Impairment

public medical data

South Korea has taken significant steps in improving healthcare with the establishment of designated centres for the safe utilization of public medical data. The Ministry of Health and Welfare has officially launched these centres, which prioritize physical, technical, and managerial security measures. They have been carefully equipped to facilitate the research utilization of public medical and clinical data.

These five esteemed centres include the Korea Health and Medical Information Service in Seoul, Keimyung University Dongsan Medical Center in Daegu, Wonju Severance Christian Hospital in Wonju, Chungnam National University Hospital in Chungnam, and the National Cancer Center (NCC) in Gyeonggi.

Excitingly, starting in June, the NCC's K-CURE project will provide cancer data through the data utilization centres, further advancing medical research and knowledge.

In parallel, South Korea has shown remarkable progress in expediting the approval process for innovative medical devices. The Ministry of Health has recently designated a VR-based software therapy for visual impairment as an innovative medical device, fast-tracking its path to approval.

Developed by the esteemed digital therapeutics company Nunaps, VIVID Brain is the first South Korean DTx solution recognized for its effectiveness in improving visual impairment caused by brain damage. It employs visual perception training techniques that enhance brain plasticity, deviating from traditional sensory compensation and substitution methods. These advancements have the potential to revolutionize the treatment of visual impairment.

To facilitate the adoption of novel medical devices in clinical settings, South Korea has made crucial changes to its approval process. This streamlined approach aims to bring cutting-edge solutions like VIVID Brain to patients in need as quickly as possible. While VIVID Brain is currently undergoing proof-of-concept studies, its future looks promising as it seeks to obtain clinical use clearance in South Korea.

Beyond South Korea, Indonesia and Iran have joined forces in the field of healthcare by launching a dedicated center for telerobotic surgery. This collaboration aims to overcome geographical barriers, allowing specialists to remotely provide their services to patients residing outside major cities. Additionally, it enables international collaboration among specialists, fostering knowledge exchange and reducing post-surgical complications and financial costs.

These advancements in medical data utilization, VR therapy, and telemedicine highlight South Korea's commitment to enhancing healthcare services and improving patient outcomes.

Comments